PubRank

Julie C Yates

Author PubWeight™ 56.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007 19.86
2 Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008 6.17
3 Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011 5.69
4 Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010 5.17
5 Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012 2.52
6 Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res 2009 2.31
7 Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest 2009 2.20
8 A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet 2011 1.98
9 Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012 1.72
10 Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. Ann Am Thorac Soc 2015 1.72
11 Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. Eur Respir J 2013 1.66
12 Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med 2013 1.41
13 Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med 2010 1.33
14 Cardiovascular events in patients with COPD: TORCH study results. Thorax 2010 1.25
15 Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med 2014 1.20
16 Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. Respir Res 2011 1.08
17 Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2014 0.78